Brain Tumour ResearchBNOS logo

BNOS Young Investigator Award 2017


BNOS Council invites nominations for a young researcher who has made an outstanding contribution to the field of neuro-oncology in the UK.  BNOS applies rigorous standards in terms of both stage of career and outputs which demonstrate a candidate’s contribution to neuro-oncology.

The recipient will be invited to speak during a dedicated session at the BNOS 2017 meeting, for which their conference fees will be waived. In addition, the recipient will receive an award of £2,000 to attend one (or more) other neuro-oncology conference in the year of the award.

Nominees should be:

  • An early career researcher, clinical or basic science candidates welcome
  • UK-based at the time of nomination


  • BNOS will only award applicants of a suitably high standard at the correct stage of their career.
  • The award is not open to candidates on substantive contracts or salaried University staff ie. Professor, Reader, Senior Lecturer, Lecturer or Consultant NHS staff.

Nominations should be accompanied by:

  • A one-page summary of the nominee’s research and its impact in neuro-oncology written by the candidate in size 12 font (Arial)
  • Copies of their most important and relevant papers (we are unable to accept papers in preparation or submitted and under peer review as evidence of output)
  • A summary CV of the candidate (no more than 3 sides of A4) including publications and prizes
  • A single page letter of support from a member of BNOS

Nominations should be submitted via email to by Friday 19th May 2017.

Nominations will be circulated to a panel of BNOS Council members for review and the successful candidate will be notified by 31st May 2017.  The panel decision is final.

The successful candidate will be invited to become a member of BNOS.

With grateful thanks to Brain Tumour Research for their generous joint sponsorship of this award.

Previous Awards were made to:

Harry Bulstrode is Clinical Lecturer at the University of Cambridge, and Honorary Specialist Registrar in Neurosurgery at Addenbrooke’s Hospital.  His main research interest is in glioma stem cell biology, especially the similarities between the transcription factor programs which control glioma stem cells and neural stem cells.  His PhD work, conducted in Steve Pollard’s labs in London and Edinburgh, was concerned with the roles of neural developmental transcription factors FOXG1 and SOX2 in establishing and maintaining glioma stem cell identity. He is now working in David Rowitch’s lab in Cambridge and has recently secured a CRUK Pioneer Award to investigate the ability of Zika Virus to infect glioma stem cells, seeking insights applicable to the development of future adjuvant therapies.

Dr Ruman Rahman, Assistant Professor in Molecular Neuro-Oncology, Faculty of Medicine & Health Sciences, The Children’s Brain Tumour Research Centre, Nottingham. “Glioma Heterogeneity: from Modelling to Therapy”

Dr Ally Rooney, trainee in neuropsychiatry, University of Edinburgh

Dr Sara Piccirillo, Research Associate at the University of Cambridge